A New Method of Predicting of the Preoperative Effectiveness of Lymph Node Dissection in Patients with Breast Cancer


Cite item

Full Text

Abstract

Relevance About 60% of patients with breast cancer to beginning of the examination and treatment have affected regional lymph node metastases, and 10% of patients with histologically pN0, additional immunohistochemical study reveals presence of micrometastases. On the other hand, low probability of hitting zones regional metastasis, based on data complementary methods of examination, would give the opportunity to evaluate effectiveness the proposed lymphadenectomy. Thus, the identification of regional lymph system in patients with primary operable breast cancer with no visualized on preoperative regional lymph nodes (N0) is an important task. The purpose of the study To improve effectiveness of preoperative prediction lymphodissection in patients with breast cancer. Materials and methods In line with the study goals and objectives were examined and treated 83 patients with primary breast cancer who were treated at the Clinic GBOU DPO RMAPO Health Ministry of Russia, Moscow and MSH Road Clinical Hospital Art. Voronezh-I JSC "Russian Railways". In addition to standard screening patients underwent planar scintigraphy mammary glands and organs of the chest with 99mTc-technetril. All data about patients, including the rating of the medical history were collected and combined into one table in Microsoft Excel format for further analysis. Results and their discussion As a result of multivariate statistical data analysis of patients in the study was a mathematical model consisting of three classifying functions, allowing to predict lymph node metastases in breast cancer. In this case, the data series are calculated each patient in three classifying functions and maximum value in one of the features include the patient to the appropriate group effectiveness lymphadenectomy. On the basis of the developed mathematical model was established and registered computer program "Preoperative evaluation of lymphadenectomy effectiveness " (registration number - 50200901168 from 12.02.2010 years), which allows preoperative patient referred to one of three groups of breast cancer with a certain percentage of probability.Based on the data generated conclusions. Conclusion The results indicate that the developed method of forecasting the number of metastatic regional lymph nodes in the preoperative stage may be included in a clinical algorithm of examination of patients with breast cancer. Specify the place planar 99mTc-MSH with technetril in the general algorithm of diagnosis of breast cancer. This study should be carried out to improve the preoperative diagnosis of breast cancer in patients with N0 or in case of questionable status of regional lymph nodes to evaluate the effectiveness of the forthcoming lymphadenectomy. In the future, the planar 99mTc-MSH with technetril help identify preoperative group of patients at low risk of metastasis to regional lymph nodes. This technique, combined with supporting biopsy "sentinel" lymph node may refuse to allow a certain number of diagnostic lymphadenectomy. Key words Lymphadenectomy, breast cancer, preoperative prediction

About the authors

N.N. Burdenko Voronezh State Medical Academy, 10 Studencheskaia Str., Voronezh, 394036,
Russian Federation

Author for correspondence.
Email: author@vestnik-surgery.com
MD, Prof., Head of department of oncology, radiation therapy and radiodiagnosis of the N.N. Burdenko Voronezh State Medical Academy

Russian Medical Academy of Postgraduate Education, 2/1 Barrikadnaia Str., Moscow, 125993,
Russian Federation

Email: author@vestnik-surgery.com
Ph.D., oncologist of clinic of the Russian Medical Academy of Postgraduate Education

N.N. Burdenko Voronezh State Medical Academy, 10 Studencheskaia Str., Voronezh, 394036,
Russian Federation

Email: author@vestnik-surgery.com
Ph.D., associated prof. of department of oncology, radiation therapy and radiodiagnosis of the N.N. Burdenko Voronezh State Medical Academy

N.N. Burdenko Voronezh State Medical Academy, 10 Studencheskaia Str., Voronezh, 394036,
Russian Federation

Email: author@vestnik-surgery.com
Ph.D., assistant of department of general surgery of N.N. Burdenko Voronezh State Medical Academy

N.N. Burdenko Voronezh State Medical Academy, 10 Studencheskaia Str., Voronezh, 394036,
Russian Federation

Email: author@vestnik-surgery.com
MD, doent assistant Professor of instrumental methods of diagnosis EITI N.N. Burdenko Voronezh State Medical Academy

MSH "Road Hospital at the Voronezh Station - 1 JSC "RZD", 2 Zdorov'ia Str., Voronezh, 394024,
Russian Federation

Email: author@vestnik-surgery.com
Ph.D., head of oncological department of "Road clinical hospital on the station Voronezh-1 of JSC RZD

MSH "Road Hospital at the Voronezh Station - 1 JSC "RZD", 2 Zdorov'ia Str., Voronezh, 394024,
Russian Federation

Email: author@vestnik-surgery.com
sugery oncological department of "Road clinical hospital on the station Voronezh-1 of JSC RZD

N.N. Burdenko Voronezh State Medical Academy, 10 Studencheskaia Str., Voronezh, 394036,
Russian Federation

Email: author@vestnik-surgery.com
MD, Prof., Head of department of general surgery of N.N. Burdenko Voronezh State Medical Academy

References

  1. Sigal Ye.I. i dr. Videotorakoskopicheskaya parasternal'naya limfadenektomiya pri rake molochnoy zhelezy. 1 Materialy s"yezda onkologov stran SNG. [Video-assisted thoracoscopic parasternal lymphadenectomy in breast cancer. Materials 1 Congress of oncologists of the CIS countries] .M., 1996; 515-516.
  2. Gabuniya R.I. Stsintigrafiya, skanirovaniye opukholey s tumorotropnymi radiofarmpreparatami. Standartizirovannyye metodiki radioizotopnoy diagnostiki. [Scintigraphy, scanning tumours with radiopharmaceuticals tumorectomy. Standardized methods of radioisotope diagnosis.] pod red. A.F. Tsyb. Obninsk, 1987; 327-334.
  3. Garin A.M., Bazin I.S. Desyat' naiboleye rasprostranennykh zlokachestvennykh opukholey. [Ten most common malignant tumors.] M .: MAKS Press, 2010; 384.
  4. Dorofeyev L.V. Kompleksnyy podkhod k otboru bol'nykh dlya organosokhranyayushchego lecheniya raka molochnoy zhelezy I, IIA, IIB stadiy [An integrated approach to the selection of patients for organ-preserving treatment of breast cancer II, IIA, IIB phase]: avtoref. dis. ... Kand. med. nauk. SPb., 1996; 20.
  5. Kanayev S.V. Sovremennyye predstavleniya o znachenii radionuklidnykh metodov v diagnostike i opredelenii stepeni rasprostranennosti raka molochnoy zhelezy. Problemy diagnostiki i lecheniya raka molochnoy zhelezy: materialy 4 mezhdunarod. konf. [Modern ideas about the significance of radionuclide techniques in the diagnosis and determining the extent of breast cancer. Problems of diagnosis and treatment of breast cancer: proceedings of the 4th international. Conf.] SPb, 2009; 30-37.
  6. Portnoy S.M. Rak molochnoy zhelezy (faktory prognoza i lecheniye) [Breast cancer (factors of prognosis and treatment)]: avtoref. dis. ... D-ra med. nauk. M., 1997.
  7. Rak molochnoy zhelezy. [Breast cancer] pod red. N.Ye. Kushlinskogo, S.M. Portnogo, K.P. Laktionova. M .: izd-vo RAMN, 2005; 480.
  8. Talakhadze N.T. Klinicheskaya otsenka stsintigrafii s 99mTs-Tekhnetrilom v diagnostike metastaticheskogo porazheniya parasternal'nykh limfouzlov u bol'nykh rakom molochnoy zhelezy [Clinical evaluation of scintigraphy with 99mTc-Mibi in the diagnosis of metastatic parasternal lymph nodes in patients with breast cancer]: dis. ... Kand. med. nauk. M., 2004; 208.
  9. Trigolosov A.V. Videotorakoskopicheskaya parasternal'naya limfodissektsiya v diagnostike i lechenii raka molochnoy zhelezy [Vats parasternal lymph node dissection in the diagnosis and treatment of breast cancer]: avtoref. dis. ... Kand. med. nauk. M., 2001; 23.
  10. Usov V.YU., Obradovich V., Kostennikov N.A. Mammostsintigrafiya: kratkiy ocherk sovremennogo klinicheskogo primeneniya. Radiologiya-praktika [Almostentirely: a brief sketch of the modern clinical use. Radiology-practice], 2001; 3: 10-23.
  11. Silverstein M.J. et al.Rassecheniye podmyshechnykh limfaticheskikh uzlov pri T1a rake molochnoy zhelezy. [Axillary lymph node dissection for T1a breast carcinoma]. Cancer, 1994; 73: 3: 664-667.
  12. Chontos A.J. et al.Rassecheniye podmyshechnykh limfaticheskikh uzlov: obyazatel'no li pri rake molochnoy zhelezy T1a. [Axillary lymph node dissection: is it required in T1a breast cancer]. J. Amer. Coll. Surg., 1997; 184: 5: 493-498.
  13. Lumachi F. et al.Obnaruzheniye metastazov podmyshechnykh limfaticheskikh uzlov s 99mTc-Sestamibi stsintimammografiyey u patsiyentov s rakom molochnoy zhelezy prokhodyashchikh khirurgicheskoye lecheniye. [Axillary lymph node metastases detection with 99mTc-sestamibi scintimammography in patients with breast cancer undergoing curative surgery]. Anticancer Res., 2001; 21:3: 2201-2205.
  14. Ronaboldo C.J. et al.Podmyshechnyy uzlovoy status u zhenshchin s ekrana raspoznavayemyye raka molochnoy zhelezy. [Axillary nodal status in women with screen-detected breast cancer]. Eur. J. Surg. Oncol., 1993; 19: 2: 130-133.
  15. Koscielny S. et al.Rak molochnoy zhelezy: vzaimosvyaz' mezhdu razmerom pervichnoy opukholi i veroyatnost' metastaticheskogo rasprostraneniya. [Breast cancer: relationship between the size of the primary tumor and the probability of metastatic dissemination]. Br. J. Cancer, 1984; 49: 709-715.
  16. Chen J.Ispol'zuya Tc-99m MIBI scintimammography differentsirovat' uzlovyye povrezhdeniya v grudi i obnaruzhivat' metastazy podmyshechnykh limfaticheskikh uzlov pri rake molochnoy zhelezy. [Using Tc-99m MIBI scintimammography to differentiate nodular lesions in breast and detect axillary lymph node metastases from breast cancer]. Chin. Med. J., 2003; I: 16: 620-624.
  17. Fournier V.D. et al.Tempy rosta pervichnoy kartsinomy molochnoy zhelezy i yeye metastazov. [Growth rate of primary mammary carcinoma and its' metastases]. Early Breast Cancer. Berlin : Springer Press, 1985; 45-47.
  18. Liberman M.Diagnostika raka grudi po stsintiomammografii: meta-analiz i obzor literatury. [Breast cancer diagnosis by scintiniammography: a meta-analysis and review of the literature]. M. Liberman. Breast. Cancer Res. Trat., 2003; 80:115-126.
  19. Mathieu I.Neopredelonnyy troynoy diagnoz v vizualizatsii raka molochnoy zhelezy: yest' mesto dlya scintimammographii? [Inconclusive triple diagnosis in breast cancer imaging: is there a place for scintimammography?]. I. Mathieu. J. Nucl. Med., 2005; 46: 1574-1578.
  20. Schillachi O.Yest' li klinicheskaya rol' scintimammographii v diagnostike raka molochnoy zhelezy? [Is there a clinical role for scintimammography in breast cancer diagnosis?]. J. Nucl. Med., 2005; 46: 1571-1573.
  21. Forrest A.P.M. et al.Edinburgskoye randomizirovannoye issledovaniye podmyshechnykh prob ili klirensa posle mastektomii. [The Edinburgh randomized trial of axillary sampling or clearance after mastectomy]. Br. J. Surg., 1995; 82: 1504-1508.
  22. R.E. White et al.Terapevticheskiye varianty i rezul'taty dlya upravleniya minimal'no invazivnoy kartsinomy molochnoy zhelezy: vliyaniye podmyshechnoy dissektsii dlya lecheniya TIA i RIB porazheniy. [Threpeutic options and results for thr management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of Tia and Tib lesions]. J.Amer. Coll. Surg., 1996; 183: 6: 575-582.
  23. Wilczek В.Dopolnitel'noye ispol'zovaniye stsintimammografi s 99mTc-MIBI utroit' diagnosticheskiye protsedury pri osyazayemykh i ne osyazayemykh porazheniyakh molochnoy zhelezy. [Complementary use of scintiniammography with 99m-Tc-MIBI to triple diagnostic procedure in palpable and non-palpable breast lesions]. Acta Radiol., 2003; 44: 288-293.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2015 ., ., ., ., ., ., ., .

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies